Skip to content

Sunstone Therapies

  • Psychedelic Therapy
  • Our Approach
  • Providers
  • About
  • Get Started

Our Offering

  • Psychedelic Therapy
  • Clinical Trials
  • Our Approach
  • Patient Resources
  • FAQs

For Providers

  • Providers
  • Refer A Patient

About Us

  • Our Mission
  • Our Team
  • Our Partners
  • Published Research
  • In The News
Enroll in a Clinical Trial

Shelby Muhammedi, L.C.S.W.

News » Shelby Muhammedi, L.C.S.W.

Recent Posts

Understanding DMT: A Closer Look at a Powerful Compound

Sunstone is pleased to begin enrollment of two clinical studies exploring the therapeutic potential of DMT (N,N-dimethyltryptamine) and its analogs.

Learn More
Sunstone Therapies Announces Publication of Long-term Benefits of Single-Dose Psilocybin in Depressed Patients with Cancer, in CANCER, the Journal of the American Cancer Society

June 16, 2025 | A new study conducted by Sunstone Therapies suggests that a single dose of psilocybin, combined with psychological support, can provide sustained relief from depression for some cancer patients.

Learn More
Get to Know Sunstone’s Co-Founder, Dr. Manish Agrawal

Manish Agrawal, MD, Co-Founder and CEO of Sunstone Therapies Manish Agrawal, MD, brings an extensive academic, clinical, and research background […]

Learn More
  • Contact Us
  • Join Our Newsletter
  • Partner With Us
  • Investors
  • Careers
  • Events
Sunstone is redefining what it means to heal by creating a safe and compassionate setting for the delivery of psychedelic-assisted therapy within a medical setting.
© 2025 Sunstone Therapies. All rights reserved.
  • Terms and Conditions
  • Privacy Policy